Social Media Press Releases
RSSShowing Press Releases with Tag: asthma
12/19/2006
MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Biowa
» read more12/13/2006
School-Based Vaccination Study With FluMist(R) Lowers Rates of Flu Among School Community and Families
» read more12/06/2006
MedImmune Reconfirms 2009 Financial Targets of $2 Billion in Revenues and $2.00 in Earnings Per Diluted Share, Excluding Share-Based Compensation Expense, at 2006 Analyst Day
» read more11/09/2006
MedImmune Files Investigational New Drug Application for Cell Culture-Based Influenza Vaccine
» read more10/13/2006
Higher Antibody Responses Observed in Young Children Receiving MedImmune’s Investigational Intranasal Influenza Vaccine Compared to Injectable Vaccine
» read more8/14/2006
MedImmune Replies to FDA’s Complete Response Letter for New Formulation of FluMist®
» read more7/31/2006
MedImmune Submits Refrigerator-Stable Formulation of FluMist® to FDA for Approval in Younger Children
» read more7/18/2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist®
» read more7/06/2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist® Vaccine Production
» read more6/15/2006
MedImmune and National Institutes of Health Begin Clinical Testing of a Live, Attenuated Intranasal Vaccine Against an H5N1 Avian Influenza Virus
» read more5/04/2006
MedImmune Awarded $170 Million, Five-Year Contract From U.S. Health and Human Services to Develop Cell-Based Influenza Vaccines
» read more5/01/2006
